Verition Fund Management
IMGN

Verition Fund Management’s Immunogen Inc IMGN Stock Holding History

Verition Fund Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-59,396
Closed -$1.76M – 3051
2023
Q4 		$1.76M Buy
+59,396
New +$1.18M 0.01% 906
2023
Q3 		– Sell
-15,513
Closed -$293K – 2767
2023
Q2 		$293K Buy
+15,513
New +$183K ﹤0.01% 1573

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Verition Fund Management's IMGN Position: Q1 2024 in Review

Verition Fund Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 59,396 shares — an estimated $1.76M sold.

Verition Fund Management first reported a position in IMGN in Q2 2023 and held it in 2 quarters. The position peaked at $1.76M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Verition Fund Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Verition Fund Management sold 59,396 Immunogen Inc shares in Q1 2024, an estimated $1.76M.
  • Verition Fund Management first reported a position in Immunogen Inc in Q2 2023 and held it in 2 quarters.
  • Verition Fund Management's Immunogen Inc position peaked at $1.76M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Verition Fund Management's 13F filing for Q1 2024, filed 14 May 2024.